For: | Zhao XJ, Li H, Chen H, Liu YX, Zhang LH, Liu SX, Feng QL. Expression of e-cadherin and β-catenin in human esophageal squamous cell carcinoma: relationships with prognosis. World J Gastroenterol 2003; 9(2): 225-232 [PMID: 12532436 DOI: 10.3748/wjg.v9.i2.225] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v9/i2/225.htm |
Number | Citing Articles |
1 |
Akira Ooki, Keishi Yamashita, Nobuyuki Kobayashi, Natsuya Katada, Shinichi Sakuramoto, Shiroh Kikuchi, Masahiko Watanabe. Lymph Node Metastasis Density and Growth Pattern as Independent Prognostic Factors in Advanced Esophageal Squamous Cell Carcinoma. World Journal of Surgery 2007; 31(11): 2184 doi: 10.1007/s00268-007-9198-9
|
2 |
Meilan Chen, Jizheng Huang, Zhenli Zhu, Jun Zhang, Ke Li. Systematic review and meta-analysis of tumor biomarkers in predicting prognosis in esophageal cancer. BMC Cancer 2013; 13(1) doi: 10.1186/1471-2407-13-539
|
3 |
Nathan W. Bronson, Brian S. Diggs, Gene Bakis, Kenneth M. Gatter, Brett C. Sheppard, John G. Hunter, James P. Dolan. Molecular Marker Expression Is Highly Heterogeneous in Esophageal Adenocarcinoma and Does Not Predict a Response to Neoadjuvant Therapy. Journal of Gastrointestinal Surgery 2015; 19(12): 2105 doi: 10.1007/s11605-015-2944-7
|
4 |
Eike Burandt, Felix Lübbersmeyer, Natalia Gorbokon, Franziska Büscheck, Andreas M. Luebke, Anne Menz, Martina Kluth, Claudia Hube-Magg, Andrea Hinsch, Doris Höflmayer, Sören Weidemann, Christoph Fraune, Katharina Möller, Frank Jacobsen, Patrick Lebok, Till Sebastian Clauditz, Guido Sauter, Ronald Simon, Ria Uhlig, Waldemar Wilczak, Stefan Steurer, Sarah Minner, Rainer Krech, David Dum, Till Krech, Andreas Holger Marx, Christian Bernreuther. E-Cadherin expression in human tumors: a tissue microarray study on 10,851 tumors. Biomarker Research 2021; 9(1) doi: 10.1186/s40364-021-00299-4
|
5 |
D.-C. Lin, X.-L. Du, M.-R. Wang. Protein alterations in ESCC and clinical implications: a review. Diseases of the Esophagus 2009; 22(1): 9 doi: 10.1111/j.1442-2050.2008.00845.x
|
6 |
Lui Ng, Ronnie Tung Ping Poon, Roberta Pang. Biomarkers for predicting future metastasis of human gastrointestinal tumors. Cellular and Molecular Life Sciences 2013; 70(19): 3631 doi: 10.1007/s00018-013-1266-8
|
7 |
Hideyuki Ishiguro, Takehiro Wakasugi, Yukio Terashita, Nobuhiro Sakamoto, Tatsuya Tanaka, Koji Mizoguchi, Hiroyuki Sagawa, Tomotaka Okubo, Hiromitsu Takeyama. Decreased expression of CDH1 or CTNNB1 affects poor prognosis of patients with esophageal cancer. World Journal of Surgical Oncology 2016; 14(1) doi: 10.1186/s12957-016-0956-8
|
8 |
K S Nair, R Naidoo, R Chetty. Expression of cell adhesion molecules in oesophageal carcinoma and its prognostic value. Journal of Clinical Pathology 2005; 58(4): 343 doi: 10.1136/jcp.2004.018036
|
9 |
Po-Kuei Hsu, Anna Fen-Yau Li, Yi-Ching Wang, Chih-Cheng Hsieh, Min-Hsiung Huang, Wen-Hu Hsu, Han-Shui Hsu. Reduced membranous β-catenin protein expression is associated with metastasis and poor prognosis in squamous cell carcinoma of the esophagus. The Journal of Thoracic and Cardiovascular Surgery 2008; 135(5): 1029 doi: 10.1016/j.jtcvs.2007.11.007
|
10 |
David S. Liu, Sanne J.M. Hoefnagel, Oliver M. Fisher, Kausilia K. Krishnadath, Karen G. Montgomery, Rita A. Busuttil, Andrew J. Colebatch, Matthew Read, Cuong P. Duong, Wayne A. Phillips, Nicholas J. Clemons. Novel metastatic models of esophageal adenocarcinoma derived from FLO-1 cells highlight the importance of E-cadherin in cancer metastasis. Oncotarget 2016; 7(50): 83342 doi: 10.18632/oncotarget.13391
|
11 |
Franz X. Bosch, Claudia Andl, Ulrich Abel, Jürgen Kartenbeck. E‐cadherin is a selective and strongly dominant prognostic factor in squamous cell carcinoma: A comparison of E‐cadherin with desmosomal components. International Journal of Cancer 2005; 114(5): 779 doi: 10.1002/ijc.20782
|
12 |
Matthew D. Taylor, Yuan Liu, Alykhan S. Nagji, Nicholas Theodosakis, David R. Jones. Combined proteasome and histone deacetylase inhibition attenuates epithelial–mesenchymal transition through E-cadherin in esophageal cancer cells. The Journal of Thoracic and Cardiovascular Surgery 2010; 139(5): 1224 doi: 10.1016/j.jtcvs.2010.01.039
|
13 |
T. Chiba, H. Kawachi, T. Kawano, J. Kumagai, K. Kitagaki, M. Sekine, K. Uchida, M. Kobayashi, K. Sugihara, Y. Eishi. Independent histological risk factors for lymph node metastasis of superficial esophageal squamous cell carcinoma; implication of claudin-5 immunohistochemistry for expanding the indications of endoscopic resection. Diseases of the Esophagus 2009; doi: 10.1111/j.1442-2050.2009.01023.x
|
14 |
Cong-Mei Wu, Tian-Hua Huang, Qing-Dong Xie, De-Sheng Wu, Xiao-Hu Xu. Expression properties of recombinant pEgr-P16 plasmid in esophageal squamous cell carcinoma induced by ionizing irradiation. World Journal of Gastroenterology 2003; 9(12): 2650-2653 doi: 10.3748/wjg.v9.i12.2650
Abstract(883) |
Core Tip(902) |
Full Article(HTML)(1898)
|
Full Article (PDF)-126K(427)
|
Times Cited (0)
|
Total Visits (4511)
|
Open
|
15 |
İpek BAYSAL, Serra ÖRSTEN. ECHINOCOCCUS GRANULOSUS SENSU STRICTO KAYNAKLI HİDATİK KİST SIVISI UYGULAMASININ CACO-2 HÜCRE HATTINDA EPİTELYAL-MEZENKİMAL GEÇİŞ VE APOPTOZ ÜZERİNE ETKİSİ. ANKEM Dergisi 2022; 36(1): 1 doi: 10.54962/ankemderg.1107804
|
16 |
Bin Li, Wen Wen Xu, Alfred King Y. Lam, Yang Wang, Hui-Fang Hu, Xin Yuan Guan, Yan Ru Qin, Nassim Saremi, Sai Wah Tsao, Qing-Yu He, Annie L. M. Cheung. Significance of PI3K/AKT signaling pathway in metastasis of esophageal squamous cell carcinoma and its potential as a target for anti-metastasis therapy. Oncotarget 2017; 8(24): 38755 doi: 10.18632/oncotarget.16333
|
17 |
Vijay Kumar, Abikshyeet Panda, Kailash Chandra Dash, Lipsa Bhuyan, Niva Mahapatra, Pallavi Mishra. Immunohistochemical Expression of the Epithelial to Mesenchymal Transition Proteins E-Cadherin and β-Catenin in Grades of Oral Squamous Cell Carcinoma. Journal of Pharmacy and Bioallied Sciences 2021; 13(Suppl 1): S555 doi: 10.4103/jpbs.JPBS_562_20
|
18 |
V. Kunene, M. Ding, M. Yap, E.A. Griffiths, P. Taniere, D. Fackrell, S. Butler, G. Contino. Prognostic markers in oesophageal and gastric cancer review. Are they ready for clinical practice?. ESMO Gastrointestinal Oncology 2024; 6: 100091 doi: 10.1016/j.esmogo.2024.100091
|
19 |
Pavlos Lampropoulos, Adamantia Zizi-Sermpetzoglou, Spyros Rizos, Alkiviadis Kostakis, Nikolaos Nikiteas, Athanasios G. Papavassiliou. Prognostic significance of transforming growth factor beta (TGF-β) signaling axis molecules and E-cadherin in colorectal cancer. Tumor Biology 2012; 33(4): 1005 doi: 10.1007/s13277-012-0333-3
|
20 |
Zhiyuan Fan, Ru Chen, Minjuan Li, Jianhua Gu, Xinqing Li, Wenqiang Wei. Association betweenCDH1methylation and esophageal cancer risk: a meta-analysis and bioinformatics study. Expert Review of Molecular Diagnostics 2022; 22(9): 895 doi: 10.1080/14737159.2022.2132853
|
21 |
H. Doucas, G. Garcea, C.P. Neal, M.M. Manson, D.P. Berry. Changes in the Wnt signalling pathway in gastrointestinal cancers and their prognostic significance. European Journal of Cancer 2005; 41(3): 365 doi: 10.1016/j.ejca.2004.11.005
|
22 |
Qian Xu, Jing Cai, Yi-Bo Cong, Shao-Jian Xiao, Yun Liu, Wei Qin, Shi-Ya Chen, Hong Shi. A Comparative Transcriptome and Proteome Analysis in Rat Models Reveals Effects of Aging and Diabetes on Expression of Neuronal Genes. International Journal of Gerontology 2016; 10(4): 212 doi: 10.1016/j.ijge.2016.05.001
|
23 |
Kong‐Jia Luo, Yi Hu, Jing Wen, Jian‐Hua Fu. CyclinD1, p53, E‐cadherin, and VEGF discordant expression in paired regional metastatic lymph nodes of esophageal squamous cell carcinoma: A tissue array analysis. Journal of Surgical Oncology 2011; 104(3): 236 doi: 10.1002/jso.21921
|
24 |
Wang-Kai Fang, Wei Gu, En-Min Li, Zhi-Yong Wu, Zhong-Ying Shen, Jin-Hui Shen, Jian-Yi Wu, Feng Pan, Zhuo Lv, Xiu-E Xu, Qiao Huang, Li-Yan Xu. Reduced membranous and ectopic cytoplasmic expression of DSC2 in esophageal squamous cell carcinoma: an independent prognostic factor. Human Pathology 2010; 41(10): 1456 doi: 10.1016/j.humpath.2010.04.003
|
25 |
Li Shang, Mingrong Wang. Molecular alterations and clinical relevance in esophageal squamous cell carcinoma. Frontiers of Medicine 2013; 7(4): 401 doi: 10.1007/s11684-013-0286-y
|
26 |
Lili Cheng, Qi Wang, Xiaoying Tao, Yanzi Qin, Qiong Wu, Dafang Zheng, Damin Chai, Yong Zhang, Dongbing Lu, Hongfei Ci, Zhiwei Wang, Jia Ma, Danna Wang, Zenong Cheng, Shiwu Wu, Yisheng Tao. FOXM 1 induces Vasculogenic mimicry in esophageal cancer through β-catenin /Tcf4 signaling. Diagnostic Pathology 2020; 15(1) doi: 10.1186/s13000-020-00929-9
|
27 |
Da-min Chai, Zheng-qi Bao, Jian-guo Hu, Li Ma, Zhen-zhong Feng, Yi-sheng Tao. Vasculogenic mimicry and aberrant expression of HIF-lα/E-cad are associated with worse prognosis of esophageal squamous cell carcinoma. Journal of Huazhong University of Science and Technology [Medical Sciences] 2013; 33(3): 385 doi: 10.1007/s11596-013-1129-4
|
28 |
Zhenchuan Ma, Jie Feng, Yurui Guo, Ranran Kong, Yuefeng Ma, Liangzhang Sun, Xiaoping Yang, Bin Zhou, Shaomin Li, Wei Zhang, Jiantao Jiang, Jin Zhang, Zhe Qiao, Yao Cheng, Danjie Zha, Shiyuan Liu. Knockdown of DDX5 Inhibits the Proliferation and Tumorigenesis in Esophageal Cancer. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2017; 25(6): 887 doi: 10.3727/096504016X14817158982636
|
29 |
Tomoya Sudo, Takeshi Iwaya, Naohiro Nishida, Genta Sawada, Yusuke Takahashi, Masahisa Ishibashi, Kohei Shibata, Hiromasa Fujita, Kazuo Shirouzu, Masaki Mori, Koshi Mimori. Expression of Mesenchymal Markers Vimentin and Fibronectin: The Clinical Significance in Esophageal Squamous Cell Carcinoma. Annals of Surgical Oncology 2013; 20(S3): 324 doi: 10.1245/s10434-012-2418-z
|
30 |
Marcelo B. Menezes, Carlos N. Lehn, Antonio J. Gonçalves. Epidemiological and histopathological data and E-cadherin-like prognostic factors in early carcinomas of the tongue and floor of mouth. Oral Oncology 2007; 43(7): 656 doi: 10.1016/j.oraloncology.2006.08.004
|
31 |
Rong Zeng, Lei Duan, Yu-Ke Kong, Xiao-Lu Wu, Ya Wang, Gang Xin, Ke-Hu Yang. Prognostic Significance of Beta-Catenin Expression in Patients with Esophageal Carcinoma: a Meta-analysis. Asian Pacific Journal of Cancer Prevention 2014; 15(15): 6103 doi: 10.7314/APJCP.2014.15.15.6103
|
32 |
Cong-Mei Wu, Tian-Hua Huang, Qing-Dong Xie, De-Sheng Wu, Xiao-Hu Xu. Construction of pETNF-P16 plasmid and its expression properties in EC9706 cell line induced by X-ray irradiation. World Journal of Gastroenterology 2004; 10(20): 2927-2930 doi: 10.3748/wjg.v10.i20.2927
Abstract(872) |
Core Tip(776) |
Full Article(HTML)(1988)
|
Full Article (PDF)-106K(313)
|
Times Cited (0)
|
Total Visits (4392)
|
Open
|
33 |
Zhi-gang CAI, Xiao-jian SHI, Yan GAO, Ming-jie WEI, Cun-yu WANG, Guang-yan YU. β-catenin expression pattern in primary oral squamous cell carcinoma. Chinese Medical Journal 2008; 121(19): 1866 doi: 10.1097/00029330-200810010-00003
|
34 |
João Adolfo Costa Hanemann, Denise Tostes Oliveira, Suely Nonogaki, Inês Nobuko Nishimoto, Marina Lara de Carli, Gilles Landman, Luiz Paulo Kowalski. Expression of E-cadherin and β-catenin in basaloid and conventional squamous cell carcinoma of the oral cavity: are potential prognostic markers?. BMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-395
|
35 |
Alexandros Charalabopoulos, Christos Golias. E-cadherin expression in Barrett’s esophagus and esophageal carcinoma. Esophagus 2014; 11(3): 153 doi: 10.1007/s10388-014-0424-x
|
36 |
Guo Zhang, Xiaobo Zhou, Liyan Xue, Lanping Quan, Yihua Wang, Cuiqi Zhou, Ning Lu, Quanhong Wang, Hongxia Zhu, Ningzhi Xu. Accumulation of cytoplasmic β‐catenin correlates with reduced expression of E‐cadherin, but not with phosphorylated Akt in esophageal squamous cell carcinoma: Immunohistochemical study. Pathology International 2005; 55(6): 310 doi: 10.1111/j.1440-1827.2005.01840.x
|
37 |
Yan Zhao, Qiaoxi Xia, Yan Liu, Wenjing Bai, Yubin Yao, Jiyu Ding, Ling Lin, Zhennan Xu, Zhixiong Cai, Shaohong Wang, Enmin Li, Haixiong Xu, Bingli Wu, Liyan Xu, Zepeng Du. TCF7L2 and EGR1 synergistic activation of transcription of LCN2 via an ERK1/2-dependent pathway in esophageal squamous cell carcinoma cells. Cellular Signalling 2019; 55: 8 doi: 10.1016/j.cellsig.2018.12.007
|
38 |
Chunni Wang, Jingnan Wang, Zhaoli Chen, Yibo Gao, Jie He. Immunohistochemical prognostic markers of esophageal squamous cell carcinoma: a systematic review. Chinese Journal of Cancer 2017; 36(1) doi: 10.1186/s40880-017-0232-5
|
39 |
Rohinton S. Tarapore, Jonathan P. Katz. Molecular Pathology of Neoplastic Gastrointestinal Diseases. Molecular Pathology Library 2013; 7: 53 doi: 10.1007/978-1-4614-6015-2_4
|
40 |
Paloma Lequerica-Fernández, Tania Rodríguez-Santamarta, Eduardo García-García, Verónica Blanco-Lorenzo, Héctor E. Torres-Rivas, Juan P. Rodrigo, Faustino J. Suárez-Sánchez, Juana M. García-Pedrero, Juan Carlos De Vicente. Prognostic Significance of β-Catenin in Relation to the Tumor Immune Microenvironment in Oral Cancer. Biomedicines 2023; 11(10): 2675 doi: 10.3390/biomedicines11102675
|
41 |
K A Voutilainen, M A Anttila, S M Sillanpää, K M Ropponen, S V Saarikoski, M T Juhola, V-M Kosma. Prognostic significance of E-cadherin–catenin complex in epithelial ovarian cancer. Journal of Clinical Pathology 2006; 59(5): 460 doi: 10.1136/jcp.2005.029876
|
42 |
T. Jäger, T. Szarvas, F. vom Dorp, C. Börgermann, M. Schenck, K.W. Schmid, H. Rübben. Einsatz der Siliziumchiptechnologie zur Detektion von Tumormarkern auf Proteinbasis beim Harnblasenkarzinom. Der Urologe 2007; 46(9): 1152 doi: 10.1007/s00120-007-1429-z
|
43 |
William L. Harryman, Kendra D. Marr, Ray B. Nagle, Anne E. Cress. Integrins and Epithelial-Mesenchymal Cooperation in the Tumor Microenvironment of Muscle-Invasive Lethal Cancers. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.837585
|
44 |
X-L. Xu, Z Q. Ling, S-Z. Chen, B. Li, W-H. Ji, W-M. Mao. The impact of E-cadherin expression on the prognosis of esophageal cancer: a meta-analysis. Diseases of the Esophagus 2014; 27(1): 79 doi: 10.1111/dote.12024
|
45 |
Yvonne Chung, Alfred K. Y. Lam, John M. Luk, Simon Law, Kwok-Wah Chan, Ping-Yin Lee, John Wong. Altered E-Cadherin Expression and p120 Catenin Localization in Esophageal Squamous Cell Carcinoma. Annals of Surgical Oncology 2007; 14(11): 3260 doi: 10.1245/s10434-007-9511-8
|
46 |
Manuela Santarosa, Roberta Maestro. The Autophagic Route of E-Cadherin and Cell Adhesion Molecules in Cancer Progression. Cancers 2021; 13(24): 6328 doi: 10.3390/cancers13246328
|
47 |
Line V. Hansen, Ole D. Lærum, Martin Illemann, Boye S. Nielsen, Michael Ploug. Altered expression of the urokinase receptor homologue, C4.4A, in invasive areas of human esophageal squamous cell carcinoma. International Journal of Cancer 2008; 122(4): 734 doi: 10.1002/ijc.23082
|
48 |
Khush Mittal. The 9 lives of β-catenin. Human Pathology 2004; 35(6): 647 doi: 10.1016/j.humpath.2004.04.006
|
49 |
Ali Razfar, Jennifer R. Grandis. Oral Cancer Metastasis. 2009; : 185 doi: 10.1007/978-1-4419-0775-2_9
|